Biochem PolskaS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-02-17
Share capital
100 000,00 PLN
Activity description

Biochem Polska is a company that specializes in providing medical products for anesthesiology, oncology, and neonatology. They offer infusion sets for administering cytostatics, temporary catheters for hemodialysis, and connectors for securing hemodialysis catheters.

Registered address
ul. Nowa 23, 05-500 Stara Iwiczna, Poland
Website
biochempolska.plWebsite active
Phone
Electronic delivery address
AE:PL-84505-84567-BAFAT-26

Financials

The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue
This companyUSD 13.18mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 11.33mMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 1.50mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 19.90mMedianUSD 539.29kAverageUSD 10.66m

Industry

Bank accounts

Registered as a VAT taxpayer on 2002-03-06. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

5 public aid cases recorded, with a total value of $7,168.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,751
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,535

Tenders

126 tenders recorded as contractor: 34 national ($540,922) and 92 EU ($47,405,248).

SubjectAmount
Dostawa wyrobów medycznych cz. I
—
Dostawa asortymentu medycznego jednorazowego użytku z możliwością składania ofert częściowych – zgodnie z wyszczególnieniem w formularzu asortymentowo- cenowym stanowiącym Załącznik nr 3 do SWZ (pakiety nr 1-34).
—
Dostawy wyrobów medycznych przeznaczonych do przygotowania i podawania leków
—

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Norbert Kruk — President of the Management Board

Manner of representation

Each member of the management board is authorised to represent the company independently.

Supervisory board

Krzysztof Andrzej Goss — Supervisory Board Member
Anna Halusiak Bujanowska — Supervisory Board Member
Anna Teresa Pawlak — Supervisory Board Member

Beneficial owners

6 beneficial owners recorded in CRBR.

Person
Krzysztof Andrzej Goss (41)
Ewa Kruk (67)
Hubert Kruk (29)
Janusz Józef Kruk (67)
Natasza Kruk (26)
Norbert Kruk (32)

Competitors

Name
Cirrosp. z o.o.
Synkmedsp. z o.o.
Midas Pharma Polskasp. z o.o.
Aquaphor Polandsp. z o.o.
Camedica Paweł Harasimiuksp. k.
Polski Lek - Dystrybucjasp. z o.o.
PromedS.A.
Biologistic Polskasp. z o.o.
Eclipse Boluk-Sobolewskasp. k.
Diather Petrusewiczsp. k.

FAQ

Last updated: 2026-07-15